ATTO CIK: 2058707

Attovia Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY19
FY20
FY21
FY24
FY25
FY19 – FY25

Assets

(positive)
Change from FY19 to FY25
billions USD
FY19:
0.55
FY20:
0.57
FY21:
0.50
FY24:
0.07
FY25:
0.16
(positive)
Change from FY19 to FY25
billions USD
FY19:
0.78
FY20:
0.61
FY21:
0.60
FY24:
0.00
FY25:
0.01
Total assets
Change from FY19 to FY25
billions USD
FY19:
1.32
FY20:
1.19
FY21:
1.10
FY24:
0.08
FY25:
0.17

Liabilities & Equity

(negative)
Change from FY19 to FY25
billions USD
FY19:
0.34
FY20:
0.40
FY21:
0.40
FY24:
0.01
FY25:
0.01
(negative)
Change from FY19 to FY25
billions USD
FY19:
0.77
FY20:
0.66
FY21:
0.71
FY24:
0.12
FY25:
0.26
(positive)
Change from FY19 to FY25
billions USD
FY19:
0.21
FY20:
0.12
FY21:
−0.01
FY24:
−0.05
FY25:
−0.11
Total liabilities & equity
Change from FY19 to FY25
billions USD
FY19:
1.32
FY20:
1.19
FY21:
1.10
FY24:
0.08
FY25:
0.17

All amounts in billions USD Data source:Twelve Data